Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Drug delivery systems for potential treatment of intracellular bacterial infections.
Imbuluzqueta E, Gamazo C, Ariza J, Blanco-Prieto MJ. Imbuluzqueta E, et al. Front Biosci (Landmark Ed). 2010 Jan 1;15:397-417. doi: 10.2741/3627. Front Biosci (Landmark Ed). 2010. PMID: 20036827 Review.
Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections.
Imbuluzqueta E, Elizondo E, Gamazo C, Moreno-Calvo E, Veciana J, Ventosa N, Blanco-Prieto MJ. Imbuluzqueta E, et al. Acta Biomater. 2011 Apr;7(4):1599-608. doi: 10.1016/j.actbio.2010.11.031. Epub 2010 Nov 27. Acta Biomater. 2011. PMID: 21115143
Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.
Imbuluzqueta E, Lemaire S, Gamazo C, Elizondo E, Ventosa N, Veciana J, Van Bambeke F, Blanco-Prieto MJ. Imbuluzqueta E, et al. J Antimicrob Chemother. 2012 Sep;67(9):2158-64. doi: 10.1093/jac/dks172. Epub 2012 May 21. J Antimicrob Chemother. 2012. PMID: 22615297
Ultra high performance liquid chromatography-tandem mass spectrometry method for cyclosporine a quantification in biological samples and lipid nanosystems.
Guada M, Imbuluzqueta E, Estella-Hermoso de Mendoza A, Lana H, Dios-Viéitez MC, Blanco-Prieto MJ. Guada M, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 May 15;927:164-72. doi: 10.1016/j.jchromb.2013.02.001. Epub 2013 Feb 8. J Chromatogr B Analyt Technol Biomed Life Sci. 2013. PMID: 23433924
Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.
Imbuluzqueta E, Gamazo C, Lana H, Campanero MÁ, Salas D, Gil AG, Elizondo E, Ventosa N, Veciana J, Blanco-Prieto MJ. Imbuluzqueta E, et al. Antimicrob Agents Chemother. 2013 Jul;57(7):3326-33. doi: 10.1128/AAC.00378-13. Epub 2013 May 6. Antimicrob Agents Chemother. 2013. PMID: 23650167 Free PMC article.
Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy.
González-Fernández Y, Imbuluzqueta E, Patiño-García A, Blanco-Prieto MJ. González-Fernández Y, et al. Among authors: imbuluzqueta e. Curr Pharm Des. 2015;21(42):6104-24. doi: 10.2174/1381612821666151027152534. Curr Pharm Des. 2015. PMID: 26503148 Review.
Clinical advances of nanocarrier-based cancer therapy and diagnostics.
Luque-Michel E, Imbuluzqueta E, Sebastián V, Blanco-Prieto MJ. Luque-Michel E, et al. Among authors: imbuluzqueta e. Expert Opin Drug Deliv. 2017 Jan;14(1):75-92. doi: 10.1080/17425247.2016.1205585. Epub 2016 Jul 7. Expert Opin Drug Deliv. 2017. PMID: 27339650 Review.
Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells.
González-Fernández Y, Imbuluzqueta E, Zalacain M, Mollinedo F, Patiño-García A, Blanco-Prieto MJ. González-Fernández Y, et al. Among authors: imbuluzqueta e. Cancer Lett. 2017 Mar 1;388:262-268. doi: 10.1016/j.canlet.2016.12.012. Epub 2016 Dec 18. Cancer Lett. 2017. PMID: 27998763
Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
Unamuno X, Imbuluzqueta E, Salles F, Horcajada P, Blanco-Prieto MJ. Unamuno X, et al. Among authors: imbuluzqueta e. Eur J Pharm Biopharm. 2018 Nov;132:11-18. doi: 10.1016/j.ejpb.2018.08.013. Epub 2018 Sep 1. Eur J Pharm Biopharm. 2018. PMID: 30179739
Cytotoxicity of nanoscaled metal-organic frameworks.
Tamames-Tabar C , Cunha D , Imbuluzqueta E , Ragon F , Serre C , Blanco-Prieto MJ , Horcajada P . Tamames-Tabar C , et al. Among authors: imbuluzqueta e. J Mater Chem B. 2014 Jan 21;2(3):262-271. doi: 10.1039/c3tb20832j. Epub 2013 Nov 22. J Mater Chem B. 2014. PMID: 32261505
15 results
Jump to page
Feedback